| Literature DB >> 30791487 |
Bethsebie Lalduhsaki Sailo1, Kishore Banik2, Sosmitha Girisa3, Devivasha Bordoloi4, Lu Fan5, Clarissa Esmeralda Halim6, Hong Wang7, Alan Prem Kumar8,9,10,11, Dali Zheng12, Xinliang Mao13,14, Gautam Sethi15, Ajaikumar Bahulayan Kunnumakkara16.
Abstract
: The FBXW7 (F-box with 7 tandem WD40) protein encoded by the gene FBXW7 is one of the crucial components of ubiquitin ligase called Skp1-Cullin1-F-box (SCF) complex that aids in the degradation of many oncoproteins via the ubiquitin-proteasome system (UPS) thus regulating cellular growth. FBXW7 is considered as a potent tumor suppressor as most of its target substrates can function as potential growth promoters, including c-Myc, Notch, cyclin E, c-JUN, and KLF5. Its regulators include p53, C/EBP-δ, Numb, microRNAs, Pin 1, Hes-5, BMI1, Ebp2. Mounting evidence has indicated the involvement of aberrant expression of FBXW7 for tumorigenesis. Moreover, numerous studies have also shown its role in cancer cell chemosensitization, thereby demonstrating the importance of FBXW7 in the development of curative cancer therapy. This comprehensive review emphasizes on the targets, functions, regulators and expression of FBXW7 in different cancers and its involvement in sensitizing cancer cells to chemotherapeutic drugs.Entities:
Keywords: FBXW7; SCF complex; cancer; chemoresistance; chemosensitization; mutations; tumor suppressor
Year: 2019 PMID: 30791487 PMCID: PMC6406609 DOI: 10.3390/cancers11020246
Source DB: PubMed Journal: Cancers (Basel) ISSN: 2072-6694 Impact factor: 6.639